Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Should kids stop bladder meds slowly or all at once? study aims to find out

NCT ID NCT06465576

Knowledge-focused Sponsor: University of Aarhus Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at the best way to stop bladder control medication in children aged 5 to 14 who are currently dry. Some children will stop their medicine suddenly, while others will taper off gradually. The goal is to see which approach lowers the chance of wetting accidents returning.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

About 216 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2024

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

5 to 14 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. The participants custody holder(s) must voluntarily sign and date an informed consent prior to initiation of any study specific procedures. 2. Age 5 to 14 years (inclusive) at the time of signing the consent and inclusion. 3. Diagnose with urinary incontinence as per ICCS criteria. 4. Pharmacological treatment with solifenacin and/or mirabegron. 5. Continence has been achieved on pharmacological therapy with solifenacin and/or mirabegron. 6. Previously withdrawal attempts are accepted. 7. Continence remained on the same dosage of medication for a minimum of three months. Exclusion Criteria: 1. Inability of the patent(s) or parental custody holder(s) to understand the Danish written and oral information. 2. Neurogenic detrusor overactivity (neurogenic bladder)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Urinary incontinence in children are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

enuresis Urinary Incontinence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Urinary incontinence in children

Contacts and locations

Locations

  • Department of Pediatric and Adolescent Medicine, Aalborg University Hospital

    Aalborg, Aalborg, 9000, Denmark

  • Department of Pediatric and Adolescent Medicine, Aarhus University Hospital

    Aarhus, Aarhus N, 8200, Denmark

  • Department of Pediatric and Adolescent Medicine, Gødstrup Hospital

    Herning, Herning, 7400, Denmark

  • Department of Pediatric and Adolescent Medicine, Kolding Hospital

    Kolding, Kolding, 6000, Denmark

  • Department of Pediatric and Adolescent medicine, Esbjerg Hospital

    Esbjerg, Esbjerg, 6700, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.